Navigation Links
Doctor Evidence, LLC Closes 2012 With Strong Sales Growth
Date:6/14/2013

Santa Monica, CA (PRWEB) June 14, 2013

Doctor Evidence, LLC continued its multiple-year trend of sustained growth with sales bookings increased over 163% year-over-year from 2011 to 2012. Revenue growth represented an increase of 100% in the same period.

Doctor Evidence’s 2012 success can be attributed both to the expansion of existing projects as well as the start of new initiatives with a varied list of clients, including academic groups, provider networks, managed care organizations, and nine of the top ten medical manufacturers (life science and device).

Among 2012 achievements was the continued collaboration between Doctor Evidence and distinguished healthcare organizations—such as Kaiser Permanente—on the development of the Guidelines Consortium, which enlists the capabilities of the Doctor Evidence product suite to create and share evidence-backed guidelines with colleagues all over the world. A wider rollout is planned for Q3 2013, with several large and prominent healthcare transformation systems joining the Doctor Evidence Guideline Consortium Network. The Guideline Consortium Network will be featured to a global audience of stakeholders at the upcoming Guidelines International Network (GIN) Conference in San Francisco, California in August 2013.

The past year also saw the launch and refinement of Doctor Evidence’s groundbreaking DOC™ Label product, which enables clients in the regulatory affairs and labeling departments of institutions to save, search, and compare over 23,000 prescription drug labels and label versions from the FDA in minutes rather than the hours or even days a more traditional search would require.

About Doctor Evidence, LLC

Doctor Evidence is a specialty software platform and services company aimed to assist stakeholders across the healthcare ecosystem to make and inform clinical and business decisions with the most relevant medical evidence. The Doctor Evidence methodology uses a Digital Outcome Conversion (DOC™) approach of taking data from published clinical studies, FDA drug labels, and epidemiological databases to transform static data into reusable, dynamic relational databases. Our software platform empowers both public and private sector clients to identify the most relevant literature and conduct ready analyses with the highest level of transparency available for today's evidence-based medicine methodological standards in the pursuit of reducing healthcare costs while increasing the quality of patient outcomes.

Doctor Evidence serves decision makers in two large addressable market segments: Medical Manufacturers and Healthcare Providers for the ultimate wellbeing of patients. Doctor Evidence is helping to transform the healthcare ecosystem by identify the most efficacious and safe medical treatment on a comparative effectiveness basis, including related economic costs and total-cost-of-care analysis.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10818390.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Happy Father's Day From Dr. Bob, "The Drugless Doctor" Offering Noteworthy Health Tips
2. Innovative Approach to Healthcare through Telemedicine by Online USA Doctors
3. Just What the Doctor Ordered: GW MFA’s EpiCURE with Chef MDs Nabs National Telly Award
4. Medical Doctor Studies, Inc Announces Open House Meetings
5. Online USA Doctors Introduces a Convenient and Affordable Alternative to Office Visits with Primary Care Physicians
6. Online USA Doctors Launches New Telemedicine Based Healthcare Plans; an Affordable Alternative to Health Insurance
7. Reynolds grant supports aging education of doctors
8. Internationally Recognized Ayurvedic Doctor Akhilesh Sharma Visits Bogota, Colombia
9. Almost Half of Cancer Doctors Report Symptoms of Burnout: Survey
10. Corporate Whistle Blower Center Urges ER Doctors Or Hospital Staff To Turn In Hospitals That Are Needlessly Admitting Patients-For Huge Whistleblower Rewards
11. Fertility Solutions Welcomes a New Doctor, Dr. Vasiliki Moragianni
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: